Calcitriol - Abbott

Drug Profile

Calcitriol - Abbott

Alternative Names: Calcijex; Dihydroxycholecalciferol - Abbott; Dihydroxyvitamin D3 - Abbott

Latest Information Update: 16 Jul 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abbott Laboratories
  • Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
  • Mechanism of Action Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hyperparathyroidism; Hypocalcaemia; Hypoparathyroidism; Osteodystrophy

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 16 Jul 1999 A phase I trial in patients with advanced cancer has been added to the therapeutic trials, adverse events and pharmacokinetics sections
  • 16 Jul 1999 Phase-I clinical trials for Cancer in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top